DocWire News Editors

DocwireNews

Iron overload is linked to higher rates of complications and mortality in patients with myelodysplastic syndromes (MDS). Increased serum ferritin, however, may not be the most accurate metric of true iron overload. Research presented at the 62nd ASH Annual Meeting &amp; Exposition explored whether higher transferrin saturation (TSAT) correlates with ferritin levels and whether TSAT can help predict clinical outcomes, such as survival, infectious death, and cardiac death.Presenter Jennifer Teichman, MD, of the University of Toronto in Canada said the study retrospectively evaluated data from 718 adult patients in the Canadian national MDS registry at 15 centers.Data included means, medians, and ranges of ferritin levels and TSAT at roughly six-month intervals. The researchers evaluated changes in ferritin levels and TSAT over time. The study also collected information on transfusion density, defined as total number of units transfused divided by months elapsed since transfusion dependence began. The researchers then compared and contrasted survival differences.&nbsp;At a median follow-up of 2.1 years:<ul>
<li>17% of the patients had developed acute myeloid leukemia (AML).</li>
<li>56% had experienced infections (median, two per patient).</li>
<li>7% had experienced a cardiac event.</li>
<li>43% had been hospitalized at least once.</li>
<li>61% of patients had died.</li>
</ul>The known causes of death were grouped as follows:<ul>
<li>AML: 26%</li>
<li>Progressive disease: 20%</li>
<li>Infection: 19%</li>
<li>Cardiac causes: 10%</li>
<li>Bleeding: 6%</li>
</ul>Ferritin increased in all patients from baseline to 42 months, but TSAT remained stable over time. Therefore, Dr. Teichman said, the two were only moderately correlated over time.Transfusion dependence remained stable over time, and it was significantly associated with infectious deaths but not cardiac events.TSAT was not significantly associated with five-year overall survival (OS), leukemia-free survival (LFS), progression-free survival (PFS), or cardiac events. But ferritin level was significantly associated with five-year OS and PFS, just not with LFS or cardiac events.&ldquo;Further analyses to probe these relationships are ongoing, including the effect of TSAT and iron chelation therapy on infectious deaths,&rdquo; Dr. Teichman said.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Transfusion Dependence and Serum Ferritin Predict Worse Outcomes in MDS, but Not Transferrin Saturation

ASH Annual Meeting 2020

Iron overload is linked to higher rates of complications and mortality in patients with myelodysplastic syndromes (MDS). Increased serum ferritin, however, may not be the most ...

Transfusion Dependence and Serum Ferritin Predict Worse Outcomes in MDS, but Not Transferrin

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe